← All Celularity INC filings

Celularity INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
CELU
Celularity INC
SCHEDULE: Lincoln Alternative Strategies Reports 0% Stake in Celularity
Lincoln Alternative Strategies LLC has filed an amended Schedule 13G, indicating it no longer holds a beneficial ownership stake in Celularity Inc.
NASDAQ
CELU
Celularity INC
SCHEDULE: Lincoln Alternative Strategies Discloses 5.14% Stake in Celularity
Lincoln Alternative Strategies LLC has reported a 5.14% beneficial ownership stake in Celularity Inc.'s Class A Common Stock.
NASDAQ
CELU
Celularity INC
SCHEDULE 13G/A: Bristol Myers Squibb and Celgene Disclose 1.9% Passive Stake in Celularity Inc.
Bristol Myers Squibb Company and its subsidiary Celgene Corporation have filed an amended Schedule 13G, disclosing a continued passive beneficial ownership of 1.9% in Celularity Inc.'s Class A Common Stock.